Evaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric Adenocarcinoma
Clinical trial NCT05504720 · COMPLETED
Trial details
- NCT number
- NCT05504720
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-13
- Primary completion
- 2026-07-15
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.